Your browser doesn't support javascript.
loading
Early Lifetime Substance Use and Development of Visual Impairment: Analysis of the National Survey on Drug Use and Health Data.
Hussain, Zain S; Khan, Asher; Loya, Asad; Shah, Kaushal; Woreta, Fasika A; Riaz, Kamran M.
Afiliação
  • Hussain ZS; University of Medicine and Health Sciences, Basseterre, Saint Kitts and Nevis.
  • Khan A; Department of Ophthalmology, Dean McGee Eye Institute, Oklahoma City, OK, USA.
  • Loya A; Department of Ophthalmology, Dean McGee Eye Institute, Oklahoma City, OK, USA.
  • Shah K; College of Medicine, University of Oklahoma, Oklahoma City, OK, USA.
  • Woreta FA; Department of Ophthalmology, Baylor College of Medicine, Houston, TX, USA.
  • Riaz KM; Department of Psychiatry and Behavioral Sciences, Oklahoma State University, Tulsa, OK, USA.
Clin Ophthalmol ; 17: 849-860, 2023.
Article em En | MEDLINE | ID: mdl-36968284
Purpose: To investigate the association between early lifetime substance use on the development of severe visual acuity impairment or blindness on a national level. Methods: National Survey of Drug Use and Health data was used to identify cases of substance use before 21* years of age, within the past year, and cases of self-reported blindness or visual impairment. Univariable and multivariable binary logistic regression with time-dependency was performed to evaluate odds of visual impairment influenced by 16 substances separated into three classes: prescription, non-prescription, and illicit drugs. Adjusted variables of interest included gender, marital status, race, level of education, total family income, poverty level, population density, and history of chronic disease. Results: 55,824 total responses were analyzed with 2577 (4.6%) cases of self-reported blindness or significant visual impairment. All early-use substance categories, including prescription, non-prescription, and illegal substances, were significantly associated with self-reported VI (OR 2.068, CI 1.451-2.949, p<0.001; OR 1.352, CI 1.227-1.489, p<0.001); OR 1.211, CI 1.086-1.352, p<0.001), respectively). Non-prescription substances displayed parallel significances amongst all constituents (alcohol, cigarettes, inhalants, and marijuana) (OR=1.227, CI 1.12-1.344, p<0.001; OR 1.363, CI 1.243-1.495, p<0.001; OR 1.418, CI 1.134-1.774; OR 1.388, CI 1.27-1.518, p<0.001, respectively). Univariable and multivariable analysis revealed several significant demographical and clinical adjustors. Conclusion: Early lifetime use of all three classes of substances is associated with enhanced odds of subsequent visual impairment or blindness. Several readily available and commonly used substances have a greater risk. These findings may help clinicians and public health agencies in mitigation ventures including education, prevention, and rehabilitation efforts.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Clin Ophthalmol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: São Cristóvão e Névis País de publicação: Nova Zelândia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Clin Ophthalmol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: São Cristóvão e Névis País de publicação: Nova Zelândia